- Home
- FSTR vs AVIR Comparison
FSTR vs AVIR Comparison
Compare FSTR & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSTR
- AVIR
- Stock Information
- Founded
- FSTR 1902
- AVIR 2012
- Country
- FSTR United States
- AVIR United States
- Employees
- FSTR N/A
- AVIR N/A
- Industry
- FSTR Metal Fabrications
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- FSTR Industrials
- AVIR Health Care
- Exchange
- FSTR Nasdaq
- AVIR Nasdaq
- Market Cap
- FSTR 304.1M
- AVIR 247.5M
- IPO Year
- FSTR N/A
- AVIR 2020
- Fundamental
- Price
- FSTR $28.47
- AVIR $3.21
- Analyst Decision
- FSTR Hold
- AVIR Hold
- Analyst Count
- FSTR 1
- AVIR 1
- Target Price
- FSTR $25.00
- AVIR $6.88
- AVG Volume (30 Days)
- FSTR 40.4K
- AVIR 353.3K
- Earning Date
- FSTR 11-07-2024
- AVIR 11-07-2024
- Dividend Yield
- FSTR N/A
- AVIR N/A
- EPS Growth
- FSTR N/A
- AVIR N/A
- EPS
- FSTR 3.85
- AVIR N/A
- Revenue
- FSTR $537,459,000.00
- AVIR N/A
- Revenue This Year
- FSTR $0.44
- AVIR N/A
- Revenue Next Year
- FSTR $7.16
- AVIR N/A
- P/E Ratio
- FSTR $7.42
- AVIR N/A
- Revenue Growth
- FSTR N/A
- AVIR N/A
- 52 Week Low
- FSTR $14.23
- AVIR $2.75
- 52 Week High
- FSTR $30.77
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- FSTR 64.66
- AVIR 52.25
- Support Level
- FSTR $27.86
- AVIR $3.04
- Resistance Level
- FSTR $29.40
- AVIR $3.24
- Average True Range (ATR)
- FSTR 0.98
- AVIR 0.16
- MACD
- FSTR -0.31
- AVIR 0.01
- Stochastic Oscillator
- FSTR 40.29
- AVIR 62.03
About FSTR L.B. Foster Company
L.B. Foster Co is a us-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through three segments: Rail Technologies and Services; Precast Concrete Products and Steel Products and Measurement. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).